Harman Finochem Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HARMAN FINOCHEM, and what generic and branded alternatives to HARMAN FINOCHEM drugs are available?
HARMAN FINOCHEM has four approved drugs.
Drugs and US Patents for Harman Finochem
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harman Finochem | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 217617-001 | Jan 18, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Harman Finochem | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214806-002 | Oct 24, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Harman Finochem | ALLOPURINOL | allopurinol | TABLET;ORAL | 214443-001 | Mar 7, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Harman Finochem | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 213320-003 | Dec 3, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Harman Finochem | BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 217617-002 | Jan 18, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Harman Finochem | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 213320-002 | Dec 3, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Harman Finochem | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214806-001 | Oct 24, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.